JALGX | JTLGX | JALGX / JTLGX | |
Total Expense Ratio | 1.38 | 1.02 | 135% |
Annual Report Gross Expense Ratio | 1.38 | 1.02 | 135% |
Fund Existence | 20 years | 20 years | - |
Gain YTD | 7.649 | 7.921 | 97% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.48B | 8.48B | 100% |
Annual Yield % from dividends | 1.84 | 2.16 | 85% |
Returns for 1 year | 9.07 | 9.48 | 96% |
Returns for 3 years | 16.38 | 17.49 | 94% |
Returns for 5 years | 14.81 | 16.58 | 89% |
Returns for 10 years | 2.58 | 5.30 | 49% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JOHAX | 26.02 | 0.04 | +0.15% |
JOHCM International Select Investor | |||
MCVAX | 11.14 | -0.03 | -0.27% |
Transamerica Mid Cap Value Opps A | |||
TRIPX | 26.09 | -0.09 | -0.34% |
Nuveen International Eq Idx Premier | |||
GSBAX | 14.83 | -0.10 | -0.67% |
Goldman Sachs Small Cap Growth C | |||
RYBOX | 55.39 | -0.86 | -1.53% |
Rydex Biotechnology A |